Sahil Khanna

Title: Sahil Khanna: Innovator in Predicting Infection Treatment Outcomes

Introduction

Sahil Khanna is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in understanding and predicting treatment outcomes for infections.

Latest Patents

Sahil Khanna holds a patent for "Biomarkers for predicting infection treatment outcome." This innovative patent provides biomarkers that can be altered in the gut of a mammal suffering from Clostridium difficile infection (CDI). The biomarkers can be utilized to predict the treatment outcome for CDI, including the response to primary treatment and the risk of recurrence. His work offers methods for predicting responses to treatment and recurrence risks, which are crucial for effective patient management.

Career Highlights

Sahil Khanna is associated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in infectious diseases. His work is pivotal in enhancing the understanding of CDI and improving treatment protocols.

Collaborations

Sahil collaborates with esteemed colleagues, including Darrell S. Pardi and Purna C. Kashyap, who contribute to the research and development of innovative solutions in the medical field.

Conclusion

Sahil Khanna's contributions to the field of infection treatment prediction are invaluable. His innovative patent and ongoing research efforts at the Mayo Foundation for Medical Education and Research highlight his commitment to improving patient outcomes.